• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. CONSULT DIAGNOSTICS HCG URINE CASSETTE; VISUAL, PREGNANCY HCG, PRESCRIPTION USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. CONSULT DIAGNOSTICS HCG URINE CASSETTE; VISUAL, PREGNANCY HCG, PRESCRIPTION USE Back to Search Results
Model Number FHC-A102
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/27/2023
Event Type  malfunction  
Manufacturer Narrative
Conclusion pending completion of investigation.H3 other text : although requested, the product has not been received.
 
Event Description
The customer reported a total of six false positive results when testing five patients using the consult diagnostics hcg urine cassette from two different lots.Patient pat-004291 was being tested prior to an unspecified procedure.The patient provided a fresh urine sample which was tested using lot 0000679523 and yielded a false positive result.A blood sample was collected the same day and a beta-hcg test was performed with a negative result (quantitative value not provided).The unspecified procedure was rescheduled, and there were no adverse patient outcomes reported.See mdrs 2027969-2023-00122, 2027969-2023-00123, and 2027969-2023-00125 for the other false positive results with lot 0000679523.See mdrs 2027969-2023-00126 and 2027969-2023-00127 for the false positive results with lot 0000700579.
 
Event Description
The customer reported a total of six false positive results when testing five patients using the consult diagnostics hcg urine cassette from two different lots.Patient (b)(6) was being tested prior to an unspecified procedure (the customer stated that the patients were being screened prior iud insertions or colposcopies, but did not specify which procedure each patient was to undergo).The patient provided a fresh urine sample which was tested using lot 0000679523 and yielded a false positive result.A blood sample was collected the same day and a beta-hcg test was performed with a negative result (quantitative value not provided).The unspecified procedure was rescheduled, and there were no adverse patient outcomes reported.See mdrs 2027969-2023-00122, 2027969-2023-00123, and 2027969-2023-00125 for the other false positive results with lot 0000679523.See mdrs 2027969-2023-00126 and 2027969-2023-00127 for the false positive results with lot 0000700579.
 
Manufacturer Narrative
D9 updated to reflect receipt of returned product on 02-jan-2024.H6 updated to reflect testing of returned product.Investigation conclusion: retained and returned devices from the reported lot numbers were tested with hcg-negative clinical urine samples.The results were read at 3 minutes and all devices yielded the expected negative results.No false positive results were observed during in-house testing.The case details were reviewed along with the complaint history for the reported issue and no indications of a systemic issue were identified.Manufacturing batch record review did not uncover any relevant non-conformances and found that the lots met quality control specifications.Review of the risk management report for this product found that the reported issue is within the risk profile for this device; no new hazard has been identified.A root cause could not be determined from the available information as the reported issue was not replicated during testing of either retention or returned product.Complaints are tracked and trended on a monthly basis.Per the package insert: ¿ very low levels of hcg (less than 50 miu/ml) are present in urine specimen shortly after implantation.However, because a significant number of first trimester pregnancies terminate for natural reasons, a test result that is weakly positive should be confirmed by retesting with a first morning urine specimen collected 48 hours later.¿ a number of conditions other than pregnancy, including trophoblastic disease and certain non-trophoblastic neoplasms including testicular tumors, prostate cancer, breast cancer, and lung cancer, cause elevated levels of hcg.Therefore, the presence of hcg in urine should not be used to diagnose pregnancy unless these conditions have been ruled out.¿ as with any assay employing mouse antibodies, the possibility exists for interference by human anti-mouse antibodies (hama) in the specimen.Specimens from patients who have received preparations of monoclonal antibodies for diagnosis or therapy may contain hama.Such specimens may cause false positive or false negative results.¿ this test provides a presumptive diagnosis for pregnancy.A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSULT DIAGNOSTICS HCG URINE CASSETTE
Type of Device
VISUAL, PREGNANCY HCG, PRESCRIPTION USE
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9942 mesa rim rd
san diego CA 92121
Manufacturer Contact
monika burrell
9942 mesa rim rd
san diego, CA 92121
8588052506
MDR Report Key18387418
MDR Text Key331504266
Report Number2027969-2023-00124
Device Sequence Number1
Product Code JHI
UDI-Device Identifier20612479202744
UDI-Public(01)20612479202744(17)250207(10)0000679523
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062361
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/31/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFHC-A102
Device Catalogue Number5001
Device Lot Number0000679523
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/30/2023
Initial Date FDA Received12/22/2023
Supplement Dates Manufacturer Received01/17/2024
Supplement Dates FDA Received01/31/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/09/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age45 YR
Patient SexFemale
-
-